Sagimet Biosciences Inc. Series A (SGMT) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Sagimet Biosciences Inc. Series A, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$10.74
+3.07% today
Market cap
$735M
Overall quality
—
Kronos AI 30-day
−17.4%
0 of 8 simulated paths end higher
Sagimet Biosciences Inc. Series A (SGMT) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $735M. It trades at $10.74, up 3.07% today. 12 analysts' average target of $28.46 implies +165.0% from today's price. Kronos AI's 30-day forecast is −17.4% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $28.46 |
| Low – high | $7.00 – $56.00 |
| Analysts | 12 |
| Upside to average | +165.0% |
Kronos AI 30-day forecast
| Expected close | $8.61 (−17.4%) |
| Likely range | −30.6% … −11.9% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.